EUVIMEDOpdag EUVIMED
Video/Audio

Preparation and Evaluation of Mouse Premature Ovarian Insufficiency Model

Diandian Jiao, Ping Zhou

Journal of Visualized Experiments · 2025

DOI: 10.3791/69000 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Diandian Jiao and 1 co-authors. Institution: The First Hospital of Anhui University of Science and Technology'; 3379439263@qq.com. Major MEDLINE topics: Primary Ovarian Insufficiency, Disease Models, Animal. Cited 3 times so far (Crossref); 14 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Premature ovarian insufficiency (POI) is a critical condition leading to female infertility, necessitating reliable animal models for mechanistic and therapeutic research. Here, we present a standardized protocol for establishing and evaluating a cyclophosphamide (CTX)-induced POI mouse model. Six-to-eight-week-old female mice with regular estrous cycles were selected and subjected to intraperitoneal CTX injections: an initial dose of 100 mg/kg on day 1, followed by daily doses of 20 mg/kg for the subsequent 14 days. Dynamic changes in estrous cycles were monitored via vaginal smear cytology with Wright staining. Serum levels of estradiol (E2), follicle-stimulating hormone (FSH), and anti-Müllerian hormone (AMH) were quantified using ELISA to assess endocrine alterations. Ovarian histopathology was evaluated through hematoxylin-eosin (H&E) staining of paraffin-embedded sections to quantify follicular atresia, while immunohistochemical analysis of cleaved caspase-3 was performed to detect granulosa cell apoptosis. Results demonstrated disrupted estrous cyclicity, significantly reduced E2 and AMH levels, elevated FSH concentrations, increased follicular atresia, and enhanced granulosa cell apoptosis in CTX-treated mice, confirming successful POI modeling. This model-building method can highly mimic the mechanism of chemotherapy-induced ovarian damage, presenting typical pathological features such as follicle reserve depletion and sex hormone disorders. It provides a reliable experimental platform for revealing the reproductive toxicity mechanism of chemotherapy, screening ovarian-protecting drugs, and optimizing fertility preservation strategies. Moreover, this model is relatively simple to operate, low-cost, and has a short production cycle, making it easy to carry out and popularize. The methodology aligns with the requirements of JoVE for visualizable, step-by-step experimental demonstrations.

Subjects

MeSH terms (MEDLINE)

Primary Ovarian InsufficiencyDisease Models, AnimalAnimalsFemaleMiceCyclophosphamideEstradiolAnti-Mullerian HormoneFollicle Stimulating HormoneOvaryEstrous Cycle

Substances

CyclophosphamideEstradiolAnti-Mullerian HormoneFollicle Stimulating Hormone

Authors and institutions

  • The First Hospital of Anhui University of Science and Technology'; 3379439263@qq.com.
  • The First Hospital of Anhui University of Science and Technology'; zhouping0708@163.com.

Cite

APA

Jiao, D., & Zhou, P. (2025). Preparation and Evaluation of Mouse Premature Ovarian Insufficiency Model. Journal of Visualized Experiments. https://doi.org/10.3791/69000

Vancouver

Jiao D, Zhou P. Preparation and Evaluation of Mouse Premature Ovarian Insufficiency Model. Journal of Visualized Experiments. 2025. doi:10.3791/69000

BibTeX
@article{Jiao2025,
  author = {Jiao, Diandian and Zhou, Ping},
  title = {Preparation and Evaluation of Mouse Premature Ovarian Insufficiency Model},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/69000}
}
Start for free →